Related Experiment Video
Updated: Jan 20, 2026

Evaluation of Cancer Stem Cell Migration Using Compartmentalizing Microfluidic Devices and Live Cell Imaging
Published on: December 23, 2011
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Nina-Naomi Kreis1, Frank Louwen2, Juping Yuan2
1Department of Gynecology and Obstetrics, University Hospital, J. W. Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany. Nina-Naomi.Kreis@kgu.de.
Abstract:
Loss of cell cycle control is characteristic of tumorigenesis. The protein p21 is the founding member of cyclin-dependent kinase inhibitors and an important versatile cell cycle protein. p21 is transcriptionally controlled by p53 and p53-independent pathways. Its expression is increased in response to various intra- and extracellular stimuli to arrest the cell cycle ensuring genomic stability. Apart from its roles in cell cycle regulation including mitosis, p21 is involved in differentiation, cell migration, cytoskeletal dynamics, apoptosis, transcription, DNA repair, reprogramming of induced pluripotent stem cells, autophagy and the onset of senescence. p21 acts either as a tumor suppressor or as an oncogene depending largely on the cellular context, its subcellular localization and posttranslational modifications. In the present review, we briefly mention the general functions of p21 and summarize its roles in differentiation, migration and invasion in detail. Finally, regarding its dual role as tumor suppressor and oncogene, we highlight the potential, difficulties and risks of using p21 as a biomarker as well as a therapeutic target.
Insights
The cell cycle protein p21, a cyclin-dependent kinase inhibitor, plays a dual role in cancer, acting as both a tumor suppressor and oncogene. Its functions in cell cycle control, differentiation, and migration are context-dependent, impacting its therapeutic potential.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Loss of cell cycle control is a hallmark of cancer.
- p21 is a key cell cycle regulator, acting as a cyclin-dependent kinase inhibitor.
- p21 expression is controlled by p53-dependent and independent pathways.
Purpose of the Study:
- To review the general functions of p21.
- To summarize the roles of p21 in differentiation, migration, and invasion.
- To discuss the potential and challenges of targeting p21 in cancer therapy.
Main Methods:
- Literature review of p21 functions.
- Analysis of p21's roles in cellular processes.
- Discussion of p21's dual role in tumorigenesis.
Main Results:
- p21 regulates cell cycle, differentiation, migration, apoptosis, DNA repair, and senescence.
- p21's function as a tumor suppressor or oncogene depends on cellular context, localization, and modifications.
- p21's involvement in differentiation, migration, and invasion is highlighted.
Conclusions:
- p21 has diverse roles beyond cell cycle arrest, including in differentiation and migration.
- The dual role of p21 necessitates careful consideration for its use as a biomarker or therapeutic target.
- Understanding p21's context-dependent functions is crucial for cancer treatment strategies.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell Migration
Cell Migration
Chemotaxis and Direction of Cell Migration

